HYPE and ZEC Spot ETFs Record $18.51 Million in Net Inflows in a Single Day

iconKuCoinFlash
Share
AI summary iconSummary
ETF news on October 29 (US Eastern Time) shows that HYPE and ZEC spot ETFs recorded a combined net inflow of $18.51 million. HYPE’s Bitwise Hyperliquid ETF (BHYP) attracted $3.70 million in inflows, with a total net asset value of $468 million and a net asset ratio of 2.11%. ZEC’s Zcash ETF (ZCSH) added $14.81 million, bringing cumulative inflows to $226 million, with a net asset value of $788 million and a net asset ratio of 3.71%. Bitcoin ETF news remains closely monitored amid rising inflows.

Odaily Planet Daily reports, according to SoSoValue data, on yesterday (Eastern Time, October 29), the U.S. HYPE spot ETF recorded a net inflow of $3.7034 million, while the ZEC spot ETF recorded a net inflow of $14.8097 million, totaling $18.5131 million.

In terms of HYPE, only the Bitwise Hyperliquid ETF (BHYP) recorded a net inflow of $3.703 million for the day, bringing its cumulative net inflow to $126 million. As of the latest update, the total net asset value of all HYPE spot ETFs is $468 million, with a net asset ratio of 2.11% and cumulative net inflows of $303 million.

On the ZEC side, Zcash ETF (ZCSH) recorded net inflows of $14.8097 million for the day, with cumulative net inflows to date amounting to $226 million. As of the time of writing, the total net asset value of ZEC spot ETFs stands at $788 million, with a net asset ratio of 3.71% and cumulative net inflows of $226 million.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.